Zymeworks Inc.

ZYME· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$21.81-0.59%

2026-08-03

Financials

Valuation Metrics

Zymeworks Inc.'s Market Cap is $1.60B. At end of 2025 it was $1.98B. Ranked #2187 of 3,111 in US market (top 70%), #858 of 1,445 on NASDAQ (top 59%), #157 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 58%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.60B	US#2,187/3,111 Sec#157/269
Revenue	$81M	US#2,824/3,111 Sec#134/269
Net Income	$-103M	US—/3,111 Sec—/269
Total Assets	$478M	US#2,764/3,111 Sec#163/269
Net Assets	$164M	US#2,794/3,111 Sec#211/269
Value
P/B	9.81x	US#2,622/3,111 Sec#204/269
P/S	19.75x	US#2,818/3,111 Sec#145/269
FCF Yield	-4.81%	US—/3,111 Sec—/269
Profitability
ROE	-62.75%	US#2,786/3,111 Sec#194/269
ROA	-21.47%	US#2,802/3,111 Sec#132/269
Op. Margin	-140.35%	US#2,843/3,111 Sec#130/269
Revenue Growth	-91.12%	US#2,936/3,111 Sec#180/269
Financial Health
Debt Ratio	192.33%	US#1,757/3,111 Sec#201/269
Total Debt	$17M	US#2,748/3,111 Sec#188/269
FCF	$-77M	US#2,543/3,111 Sec#132/269
Cash	$244M	US#1,578/3,111 Sec#97/269
Current Ratio	10.82x	US#226/3,111 Sec#75/269
Performance
1Y Return	73.51%	US#436/3,111 Sec#96/269
1M Return	-17.10%	US#2,694/3,111 Sec#213/269
From 52W High	-26.69%	US#1,957/3,111 Sec#139/269
1Y MDD	-23.63%	US#898/3,111 Sec#46/269
Trading
Volume	382,582 shares	US#2,282/3,111 Sec#226/269
Trading Value	$8M	US#2,427/3,111 Sec#197/269
Per Share
EPS	$-1.08	US—/3,111 Sec—/269
BPS	$3.56	US#2,367/3,111 Sec#153/269